112 related articles for article (PubMed ID: 3657392)
1. Relative selectivity of some conformationally constrained tryptamine analogs at 5-HT1, 5-HT1A and 5-HT2 recognition sites.
Taylor EW; Nikam S; Weck B; Martin A; Nelson D
Life Sci; 1987 Oct; 41(16):1961-9. PubMed ID: 3657392
[TBL] [Abstract][Full Text] [Related]
2. Molecular determinants for recognition of RU 24969 analogs at central 5-hydroxytryptamine recognition sites: use of a bilinear function and substituent volumes to describe steric fit.
Taylor EW; Nikam SS; Lambert G; Martin AR; Nelson DL
Mol Pharmacol; 1988 Jul; 34(1):42-53. PubMed ID: 3393140
[TBL] [Abstract][Full Text] [Related]
3. Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin.
Hoyer D; Engel G; Kalkman HO
Eur J Pharmacol; 1985 Nov; 118(1-2):13-23. PubMed ID: 2935410
[TBL] [Abstract][Full Text] [Related]
4. A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system.
Dumuis A; Bouhelal R; Sebben M; Cory R; Bockaert J
Mol Pharmacol; 1988 Dec; 34(6):880-7. PubMed ID: 2849052
[TBL] [Abstract][Full Text] [Related]
5. 1-(2-Aminoethyl)-3-methyl-8,9-dihydropyrano[3,2-e]indole: a rotationally restricted phenolic analog of the neurotransmitter serotonin and agonist selective for serotonin (5-HT2-type) receptors.
Macor JE; Fox CB; Johnson C; Koe BK; Lebel LA; Zorn SH
J Med Chem; 1992 Oct; 35(20):3625-32. PubMed ID: 1433172
[TBL] [Abstract][Full Text] [Related]
6. N(1)-substituted ergolines and tryptamines show species differences for the agonist-labeled 5-HT2 receptor.
Johnson MP; Audia JE; Nissen JS; Nelson DL
Eur J Pharmacol; 1993 Aug; 239(1-3):111-8. PubMed ID: 8223886
[TBL] [Abstract][Full Text] [Related]
7. Selectivity of serotonergic drugs for multiple brain serotonin receptors. Role of [3H]-4-bromo-2,5-dimethoxyphenylisopropylamine ([3H]DOB), a 5-HT2 agonist radioligand.
Titeler M; Lyon RA; Davis KH; Glennon RA
Biochem Pharmacol; 1987 Oct; 36(19):3265-71. PubMed ID: 3663239
[TBL] [Abstract][Full Text] [Related]
8. Tetrahydro-beta-carbolines: affinities for tryptamine and serotonergic binding sites.
Cascio CS; Kellar KJ
Neuropharmacology; 1982 Nov; 21(11):1219-21. PubMed ID: 7177348
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of tryptamine binding sites following chronic molindone administration. A comparison with responses of dopamine and 5-hydroxytryptamine receptors.
Nguyen TV; Juorio AV
Naunyn Schmiedebergs Arch Pharmacol; 1989 Oct; 340(4):366-71. PubMed ID: 2586632
[TBL] [Abstract][Full Text] [Related]
10. Effect of chronic treatment with 5-HT1 agonist (8-OH-DPAT and RU 24969) and antagonist (isapirone) drugs on the behavioural responses of mice to 5-HT1 and 5-HT2 agonists.
De Souza RJ; Goodwin GM; Green AR; Heal DJ
Br J Pharmacol; 1986 Oct; 89(2):377-84. PubMed ID: 2946344
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and serotonin receptor affinities of a series of enantiomers of alpha-methyltryptamines: evidence for the binding conformation of tryptamines at serotonin 5-HT1B receptors.
Nichols DE; Lloyd DH; Johnson MP; Hoffman AJ
J Med Chem; 1988 Jul; 31(7):1406-12. PubMed ID: 3385733
[TBL] [Abstract][Full Text] [Related]
12. Species differences in the pharmacology of the 5-hydroxytryptamine2 receptor: structurally specific differentiation by ergolines and tryptamines.
Nelson DL; Lucaites VL; Audia JE; Nissen JS; Wainscott DB
J Pharmacol Exp Ther; 1993 Jun; 265(3):1272-9. PubMed ID: 8510008
[TBL] [Abstract][Full Text] [Related]
13. Identification of a 5-HT1 recognition site in human brain membranes different from 5-HT1A, 5-HT1B and 5-HT1C sites.
Hoyer D; Waeber C; Pazos A; Probst A; Palacios JM
Neurosci Lett; 1988 Mar; 85(3):357-62. PubMed ID: 2966310
[TBL] [Abstract][Full Text] [Related]
14. Tryptamine binding sites: potential site of action of tetrahydro-beta-carbolines.
Kellar KJ; Cascio CS
Prog Clin Biol Res; 1982; 90():209-12. PubMed ID: 7111320
[No Abstract] [Full Text] [Related]
15. Structural relationships in the inhibition of [3H]tryptamine binding to rat brain membranes in vitro by phenylalkylamines.
Martin LL; Roland DM; Neale RF; Wood PL
Eur J Pharmacol; 1986 Dec; 132(1):53-5. PubMed ID: 3816964
[TBL] [Abstract][Full Text] [Related]
16. Indoloquinolizidines, formal derivatives of tetrahydro-beta-carbolines, show selective affinity for benzodiazepine, tryptamine and serotonin binding sites in rat brain.
Lounasmaa M; Saano V; Airaksinen MM; Jokela R; Huhtikangas A
Neuropharmacology; 1986 Aug; 25(8):915-8. PubMed ID: 3774117
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of two 5-hydroxytryptamine receptors coupled to adenylate cyclase in guinea pig hippocampal membranes.
Shenker A; Maayani S; Weinstein H; Green JP
Mol Pharmacol; 1987 Apr; 31(4):357-67. PubMed ID: 2952874
[TBL] [Abstract][Full Text] [Related]
18. Binding of O-alkyl derivatives of serotonin at human 5-HT1D beta receptors.
Glennon RA; Hong SS; Bondarev M; Law H; Dukat M; Rakhi S; Power P; Fan E; Kinneau D; Kamboj R; Teitler M; Herrick-Davis K; Smith C
J Med Chem; 1996 Jan; 39(1):314-22. PubMed ID: 8568822
[TBL] [Abstract][Full Text] [Related]
19. Displacement of serotonin from binding sites in rat cortex: the effects of biogenic "trace" amines.
Locock RA; Baker GB; Coutts RT; Dewhurst WG
Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(4-6):701-4. PubMed ID: 6531441
[TBL] [Abstract][Full Text] [Related]
20. The activation of serotonin receptors by tryptamine induces hyperinsulinemia in mice.
Yamada J; Sugimoto Y; Kimura I; Takeuchi N; Horisaka K
Eur J Pharmacol; 1990 Jun; 181(3):319-22. PubMed ID: 2200694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
